Healthcare Blogs

  Cell Viability Assays Market Highlights Cell Viability Assays Market overview and analysis by product, cell type, application, end-user - forecast till 2030. Cell viability assays is a type of technique that is used for determining viable cells in the culture. Market Research Future (MRFR) has published a research report about the global cell viability assays market is anticipated to reach USD 3.83 billion by 2030 at 8.50% CAGR during the forecast period 2022-2030. The imperative factor driving the global cell viability assays market report growth is the growing prevalence of chronic ailments and infectious diseases. Other important factors aiding the market growth include growing availability of funds for cell-based research, increasing focus on developing cell-based therapeutics, and the rising need of cell-based assays in research and development (R&D) activities. Market Regional Analysis The regional segmentation of the global cell viability assays market has segment

  Veterinary CBD Market Analysis    The veterinary CBD market is predicted to reach USD 410.41 Million at a 53.4% CAGR between 2022 - 2030, according to the recent Market Research Future (MRFR) report. Pet/veterinary CBD treatment, simply put, is the treatment offered to pets for treating various diseases, including seizures, cancer, anxiety, and more. It is generally derived from two sources- hemp and marijuana.    Different factors are propelling the growth of the veterinary CBD market such as fewer side effects, burgeoning demand by pet owners for organic healthcare products, different benefits of using pet CBD such as to treat osteoarthritis, reduce tiredness and fatigue, balance mood swings, maintain mental health, and manage pet pain, seizures, and anxiety. Besides, a rise in the number of household pets, an increase in the willingness to invest in pet healthcare, no requirement for customization, new and untapped market, and low implementation cost are also adding marke

  Pain Relief Medication Market Highlights Pain relief medicine is a branch of medicine that employs an interdisciplinary approach for easing the suffering and improving the quality of life of those living with acute as well as chronic pain. The growth of the global pain relief medication market overview is driven by several factors such as increasing patient population suffering from chronic pain and cancer pain, increasing research in the pain management field, and rising product launch in the pain relief medication market. However, the stringent regulations and high cost of drugs are likely to hamper the growth of the global pain relief medication market. Several market players currently dominate the global pain relief medication market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in July 2018, AbbVie received approval for Orilissa (elagolix) from the US Food and Drug Administration (FDA) fo

  Blood Flow Measurement Devices Market Highlights Blood flow measurement devices are measurement devices that are used by the physician to understand the nature of the blood flow such as the amount of blood supplied to various vital organs and abnormal changes in the blood flow velocity, which can cause malformation of vessels. Blood Flow Measurement Devices Market Size was valued at USD 0.2 billion in 2022. The Blood Flow Measurement Devices market industry is projected to grow from USD 0.217 Billion in 2023 to USD 0.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8% during the forecast period (2023 - 2030). The growth of the market is due to the increasing cardiovascular disorders, increasing obesity rates, and growing demand for minimally invasive procedures. Entering the untapped market is an opportunity for the blood flow measurement devices market. Similarly, the high cost of the devices and lack of skilled professionals can hamper the growth of the

  Insulin Biosimilars Market Highlights A disease in which the body’s ability to produce or respond to the hormone insulin is impaired, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood is termed diabetes. Biosimilar insulin is designed to be highly like the original, or reference, insulin product described in a patent. As patents for major branded insulin products start to expire, several biosimilar insulin markets are expected to launch in the coming years. According to MRFR analysis, the Insulin Biosimilars Market was valued at USD 2311 Million in 2019 and is expected to register a CAGR of14.80% during the forecast period of 2022 to 2030. The USFDA approved new insulin glargine Basilar, for type 1 and type 2 diabetes which is a biosimilar version of Sanofi’s basal insulin Lantus (insulin glargine). Additionally, Lilly and Boehringer Ingelheim’s biosimilar insulin glargine has got approval through the European Medicines Agency’s (EMA

  Aesthetics Market Overview   The global aesthetics market, during the forecast period 2022 to 2030, will register growth at a CAGR of 13.92%. The market for aesthetics is set to reach USD 320 billion by 2030. As per the aesthetics market overview , the global market is anticipated to witness growth owing to the factors such as non-invasive and minimally invasive aesthetic procedures as well as the demand for non-invasive and minimally invasive aesthetic procedures. However, the aesthetics market will face challenges and restraints due to risks associated with aesthetic procedures and the growing demand for advanced devices during the forecast period 2022 to 2030. Emergence of technically innovative devices in the market is set to play a key role in determining the growth potential during 2022 to 2030 years. Analysts have also studied the aesthetics market to understand potential threats and challenges the market companies could face. Although the aesthetics market is poised to gr

Bone Graft Substitutes Market Synopsis: Market Research Future (MRFR)’s latest study reveals that the Bone Graft Substitute Market is projected to reach USD 2,121.66 million by 2030 at 6.80% CAGR during the forecast period 2022-2030. The increasing prevalence of diseases related to bones has intensified the demand for bone graft substitutes. Additionally, the rising awareness about the developments in bone graft substitutes coupled with rising healthcare expenditure is likely to augment the market size and revenue over the next couple of years. The painful procedure related to autografts have paved the way for developments in the bone graft substitutes market trends . Hence, the demand for alternatives such as allografts, xenografts, and synthetic bone grafts has been on the rise. It is projected to aid the proliferation of the market in the forthcoming years by accelerating its adoption. The growth of the bone graft substitutes market is guided by the factors such as increasing